Log in or register
Share on LinkedInShare on LinkedIn

ARTICLE · 23 SEPTEMBER 2024

Bitkiden İlaca: Kenevirin İlaç Endüstrisine Girişi

Gün + Partners
Gün + Partners
Contributor
Gün + Partners

Gün + Partners

We are one of the oldest and largest law firms in Turkey and are considered internationally to be...

View firm profile
Explore more from Gün + Partners

Tarım ve Orman Bakanlığı ("Bakanlık") tarafından hazırlanan İlaç Etkin Maddesi Üretimi Amaçlı Kenevir Yetiştiriciliği ve Kontrolüne Dair Yönetmelik ("Yönetmelik")...

TurkeyCannabis & Hemp
Dicle Doğan
Dicle Doğan
Beste Turan
Beste Turan
Author LinkedIn connections

Tarım ve Orman Bakanlığı (“Bakanlık”) tarafından hazırlanan İlaç Etkin Maddesi Üretimi Amaçlı Kenevir Yetiştiriciliği ve Kontrolüne Dair Yönetmelik (“Yönetmelik”) 13 Eylül 2024 tarihinde 32661 sayılı Resmi Gazete'de yayımlanarak yürürlüğe girdi. Yönetmelik; ilaç etkin maddesi elde etmeye yönelik kenevir yetiştiriciliğinin; kontrolü, hasadı, değerlendirilmesi, işlenmesi, imhası, ihzarı, ihracı ve/veya satın alınması/satılması ile bilimsel araştırma amaçlı izin verilen kurum/kuruluşların kenevirden elde edilen çiçek ve yaprakları amacı dışında kullanmalarını engelleyecek her türlü tedbirin alınmasını, gerekli kontrollere ilişkin görev ve sorumluluklar ile denetim esaslarını kapsayacak hükümler içermektedir.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Register for freeORLog in

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

View source

Related Articles

Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics

Read more about

See more popular content from

Article

Data Protection And Privacy Law In Türkiye Key Developments And Predictions - 2026

This comprehensive report examines the evolving landscape of personal data protection in Türkiye, analyzing regulatory developments, enforcement trends, and emerging compliance challenges through 2025 and into the first half of 2026. The analysis covers the Turkish Personal Data Protection Authority's expanding guidance framework, significant enforcement actions totaling TRY 352.5 million in fines, and critical regulatory shifts including new cybersecurity legislation and constitutional court decisions
TurkeyPrivacy
Gün + Partners
Gün + Partners
Article

New Pricing Communiqué Following The New Pricing Decision For Medicinal Products For Human Use: Increase Of The Euro Conversion Rate To 65% Of The Previous Year’s Average And Details Of The Pricing Incentive For The First Equivalent/Generic Product

Turkey's pharmaceutical pricing system undergoes a major restructuring with the publication of the New Pricing Communiqué on August 29, 2026, implementing significant changes including increased Euro/TRY conversion rates, incentive mechanisms for first generic market entry, and the introduction of value-based pricing concepts. The new regulations establish detailed provisions for special product categories while leaving certain implementation details to future secondary legislation.
TurkeyFood, Drugs, Healthcare, Life Sciences
Gün + Partners
Gün + Partners
Article

Copyright Law In TÜRKİYE Key Developments And Predictions - 2026

The rapidly evolving digital ecosystem has transformed copyright law from a technical field into a central topic of economic and societal debate. This comprehensive review examines significant developments in Turkish copyright law as of 2025, exploring how artificial intelligence, digital content creation, press publishing rights, and the sports industry are challenging existing legal frameworks and reshaping the balance between right holders and users.
TurkeyIntellectual Property
Gün + Partners
Gün + Partners